Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Proliferative Breast Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 18 of 0 results

Not applicableStudy completedNCT01016665
What this trial is testing

Anastrozole Reduced Proliferation and Progesterone Receptor Indexes in Short Term Hormone Therapy

Who this might be right for
Breast Cancer
Federal University of São Paulo 71
Testing effectiveness (Phase 2)Study completedNCT03454529
What this trial is testing

The Effect of Simvastatin on Breast Cancer Cell Growth in Women With Stage I-II Breast Cancer

Who this might be right for
Invasive Breast CarcinomaStage I Breast Cancer AJCC v7Stage IA Breast Cancer AJCC v7+4 more
Michael Simon 24
Not applicableStudy completedNCT06309459
What this trial is testing

Carbonic Anhydrase IX Enzyme in Triple Negative Breast Carcinoma

Who this might be right for
Triple Negative Breast CancerCarbonic Anhydrase IX
Kahramanmaras Sutcu Imam University 40
Not applicableStudy completedNCT03860740
What this trial is testing

Effect of Physical Exercise on Tumor Proliferation of Luminal B Breast Cancer Patients

Who this might be right for
Breast CancerLuminal B
Spanish Breast Cancer Research Group 12
Very early researchStudy completedNCT02802748
What this trial is testing

Phase 0 Study of Metronomic Oral Vinorelbine and Letrozole in HR+/HER2-negative Early Breast Cancer Patients (VENTANA)

Who this might be right for
Breast Cancer
SOLTI Breast Cancer Research Group 60
Testing effectiveness (Phase 2)Study completedNCT02729701
What this trial is testing

Pilot Study of the Effect of Duavee® on Benign Breast Tissue Proliferation

Who this might be right for
Breast Cancer
University of Kansas Medical Center 28
Testing effectiveness (Phase 2)Active Not RecruitingNCT02603679
What this trial is testing

Neoadjuvant Response-guided Treatment of Luminal B-type Tumors and Luminal A-type Tumors With Node Metastases

Who this might be right for
Early-Stage Breast CarcinomaEstrogen Receptor Positive Tumor
Thomas Hatschek 181
Testing effectiveness (Phase 2)Study completedNCT00016549
What this trial is testing

Bevacizumab to Treat Inflammatory Breast Cancer or Locally Advanced Breast Cancer

Who this might be right for
Breast Cancer
National Cancer Institute (NCI) 21
Testing effectiveness (Phase 2)Study completedNCT00982319
What this trial is testing

Study to Evaluate the Effect of Sulforaphane in Broccoli Sprout Extract on Breast Tissue

Who this might be right for
Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 34
Testing effectiveness (Phase 2)Study completedNCT01605396
What this trial is testing

A Phase II Trial of Ridaforolimus and Exemestane, Compared to Ridaforolimus, Dalotuzumab and Exemestane in Participants With Breast Cancer (MK-8669-064)

Who this might be right for
Breast Neoplasms
Merck Sharp & Dohme LLC 80
Not applicableActive Not RecruitingNCT03657628
What this trial is testing

Physical Activity, Proliferation and Immune Markers in Benign Breast Tissue

Who this might be right for
Breast Cancer
Dana-Farber Cancer Institute 60
Testing effectiveness (Phase 2)WithdrawnNCT00252811
What this trial is testing

ZD1839 Effects on Cell Proliferation in Breast Cancer

Who this might be right for
Breast Cancer
AstraZeneca 60
Not applicableStudy completedNCT03886389
What this trial is testing

Breast Cancer Diet Intervention Study

Who this might be right for
Early-stage Breast CancerCarbohydrate EngorgementProliferation+2 more
Helse Stavanger HF 80
Testing effectiveness (Phase 2)Ended earlyNCT01934335
What this trial is testing

Effect of Vandetanib on Cellular Markers in Invasive Breast Cancer

Who this might be right for
Invasive Breast Cancer
Ronald Weigel 12
Testing effectiveness (Phase 2)Study completedNCT00930579
What this trial is testing

Pre-Surgical Study: Effect of Metformin on Breast Cancer Proliferation

Who this might be right for
Breast Cancer
Columbia University 35
Not applicableEnded earlyNCT02095184
What this trial is testing

GCC 1366: Anti-Proliferative Response to NeoAdjuvant AIs in Overweight and Obese Patients

Who this might be right for
Breast Cancer
University of Maryland, Baltimore 42
Not applicableStudy completedNCT00612560
What this trial is testing

Flaxseed, Aromatase Inhibitors and Breast Tumor Characteristics

Who this might be right for
Breast Cancer
Roswell Park Cancer Institute 28
Very early researchStudy completedNCT03197389
What this trial is testing

Effect of Pembrolizumab (Keytruda®) on Biomarkers in Early Breast Cancer.

Who this might be right for
Breast CancerTriple Negative Breast CancerHormone Receptor Negative Neoplasm
Universitaire Ziekenhuizen KU Leuven 54